Multiple proteolytic systems, including the proteasome, contribute to CFTR processing.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Cell

• Publication date

  1995-10-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0092-8674(95)90241-4PMID 7553864
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of molecular chaperones in intracellular protein breakdown.

  1996cited by this paper
• Stress-Inducible Cellular Responses

  1996cited by this paper
• Functions of the proteasome: the lysis at the end of the tunnel.

  1995cited by this paper
• New insights into proteasome function: from archaebacteria to drug development.

  1995cited by this paper
• Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

  1995cited by this paper
• Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins.

  1994cited by this paper
• The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.

  1994cited by this paper
• Regulated intracellular degradation of apolipoprotein B in semipermeable HepG2 cells.

  1994cited by this paper
• The molecular basis of chloride transport in shark rectal gland.

  1994cited by this paper
• The ABC‐transporter Ste6 accumulates in the plasma membrane in a ubiquitinated form in endocytosis mutants.

  1994cited by this paper
• Prolonged association of temperature-sensitive mutants of human P-glycoprotein with calnexin during biogenesis.

  1994cited by this paper
• Components of a system that ligates cyclin to ubiquitin and their regulation by the protein kinase cdc2.

  1994cited by this paper
• Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator.

  1994influential reference
• Activation-dependent ubiquitination of a T cell antigen receptor subunit on multiple intracellular lysines.

  1994cited by this paper
• Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP.

  1994influential reference
• Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

  1994influential reference
• The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment.

  1993cited by this paper
• A protein translocation defect linked to ubiquitin conjugation at the endoplasmic reticulum

  1993influential reference
• Rapid degradation of an unassembled immunoglobulin light chain is mediated by a serine protease and occurs in a pre-Golgi compartment.

  1993cited by this paper
• Proteasomes: multicatalytic proteinase complexes.

  1993cited by this paper
• Cell surface control of the multiubiquitination and deubiquitination of high‐affinity immunoglobulin E receptors.

  1993cited by this paper
• Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites.

  1993cited by this paper
• The mechanism and functions of ATP-dependent proteases in bacterial and animal cells.

  1992cited by this paper
• Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination

  1992cited by this paper
• Involvement of the chaperonin dnaK in the rapid degradation of a mutant protein in Escherichia coli.

  1992cited by this paper
• Endoplasmic reticulum degradation of a subunit of the asialoglycoprotein receptor in vitro. Vesicular transport from endoplasmic reticulum is unnecessary.

  1992cited by this paper
• Mislocalization of ΔF508 CFTR in cystic fibrosis sweat gland

  1992cited by this paper
• 3-Hydroxy-3-methylglutaryl-coenzyme A reductase and T cell receptor alpha subunit are differentially degraded in the endoplasmic reticulum.

  1992cited by this paper
• The ubiquitin system for protein degradation.

  1992cited by this paper
• Cystic fibrosis: molecular biology and therapeutic implications.

  1992cited by this paper
• Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland.

  1992cited by this paper
• Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR).

  1992cited by this paper
• Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance.

  1991cited by this paper
• A cross-species analysis of the cystic fibrosis transmembrane conductance regulator. Potential functional domains and regulatory sites.

  1991cited by this paper
• CFTR: development of high- affinity antibodies and localization in sweat gland.

  1991cited by this paper
• Nonlysosomal, pre-Golgi degradation of unassembled asialoglycoprotein receptor subunits: a TLCK- and TPCK-sensitive cleavage within the ER

  1991cited by this paper
• Phosphorylation-regulated CI− channel in CHO cells stably expressing the cystic fibrosis gene

  1991cited by this paper
• Inhibition of degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo by cysteine protease inhibitors.

  1991cited by this paper
• Degradation of T-cell receptor chains in the endoplasmic reticulum is inhibited by inhibitors of cysteine proteases.

  1991cited by this paper
• The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins.

  1990cited by this paper
• Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

  1990influential reference
• Protein degradation in the endoplasmic reticulum.

  1990cited by this paper
• Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA

  1989cited by this paper
• Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

  1989cited by this paper
• Identification of the cystic fibrosis gene: genetic analysis.

  1989cited by this paper
• Identification of the cystic fibrosis gene: genetic analysis

  1989cited by this paper
• Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

  1985influential reference
• A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes.

  1977cited by this paper

• RFFL-mediated protein quality control limits functional rescue of TRID-CFTR modulator combination therapy for cystic fibrosis nonsense mutations

  2026cites this paper
• Functional integrity of the SEL1L–HRD1 complex is critical for endoplasmic reticulum–associated degradation and organismal viability

  2026cites this paper
• Structural basis and pathological implications of the dimeric OS9-SEL1L-HRD1 ERAD Core Complex

  2026cites this paper
• Reconstitution of CFTR ubiquitination identifies lysine-420 as a regulator of cell surface residence and current

  2025cites this paper
• Introduction of Ivacaftor/Lumacaftor in Children With Cystic Fibrosis Homozygous for F508del in the Netherlands: A Nationwide Real‐Life Study

  2025cites this paper
• Recent developments in cystic fibrosis drug discovery: where are we today?

  2025cites this paper
• Antisense oligonucleotide targeting the E3 ligase RFFL potentiates CFTR modulator efficacy in CF primary bronchial epithelial cells

  2025cites this paper
• Synergistic Control of Mitochondrial Dynamics and Function by ERAD and Autophagy in Brown Adipocytes

  2025cites this paper
• Functional integrity of the SEL1L-HRD1 complex is critical for ERAD and organismal viability

  2025cites this paper
• Barriers to the Pharmacologic Rescue of W1282X CFTR

  2025cites this paper
• Structural basis and pathological implications of the dimeric OS9-SEL1L-HRD1 ERAD Core Complex

  2025cites this paper
• Parkinson's disease‐linked Kir4.2 mutation R28C leads to loss of ion channel function

  2025cites this paper
• REpair of heterozygous Mutations independent of Exogenous Donor template with high efficiency (REMEDY) using allele specific CRISPR targeting and HDR enhancers

  2025cites this paper
• Proteasome: Role in T Cell Function Regulation

  2025cites this paper
• SEL1L–HRD1-mediated ERAD in mammals

  2025cites this paper
• Vibrio MARTX toxin processing and degradation of cellular Rab GTPases by the cytotoxic effector Makes Caterpillars Floppy

  2024cites this paper
• PTI-801 (posenacaftor) shares a common mechanism with VX-445 (elexacaftor) to rescue p.Phe508del-CFTR.

  2024cites this paper
• Ligand-based virtual-screening identified a novel CFTR ligand which improves the defective cell surface expression of misfolded ABC transporters

  2024cites this paper
• Protein Quality Control of NKCC2 in Bartter Syndrome and Blood Pressure Regulation

  2024cites this paper
• Targeting ubiquitination machinery in cystic fibrosis: Where do we stand?

  2024cites this paper
• Identification of Polycystin 2 Missense Mutants Targeted for Endoplasmic Reticulum-Associated Degradation.

  2024cites this paper
• HERC3 facilitates ERAD of select membrane proteins by recognizing membrane-spanning domains

  2024cites this paper
• Characterization of hyperactive mutations in the renal potassium channel ROMK uncovers unique effects on channel biogenesis and ion conductance

  2024influential citation
• Genome mining yields putative disease-associated ROMK variants with distinct defects

  2023cites this paper
• Elexacaftor Mediates the Rescue of F508del CFTR Functional Expression Interacting with MSD2

  2023cites this paper
• Efficacy of targeted therapy with lumacaftor/ivacaftor in children with cystic fibrosis (12-month follow-up)

  2023cites this paper
• Respiratory Infection and Inflammation in Cystic Fibrosis: A Dynamic Interplay among the Host, Microbes, and Environment for the Ages

  2023cites this paper
• Transmembrane Helices 7 and 8 Confer Aggregation Sensitivity to the Cystic Fibrosis Transmembrane Conductance Regulator

  2023cites this paper
• Influence of Combretum nigricans Hot Aqueous Extracts on Phenylhadrazine- Induced Hemolytic Anaemia in Wistar Rats

  2023influential citation
• Genome mining yields new disease-associated ROMK variants with distinct defects

  2023cites this paper
• Small-molecule correctors divert CFTR-F508del from ERAD by stabilizing sequential folding states

  2023cites this paper
• Small molecule correctors divert CFTR-F508del from ERAD by stabilizing sequential folding states

  2023cites this paper
• Pervasive aggregation and depletion of host and viral proteins in response to cysteine-reactive electrophilic compounds

  2023cites this paper
• UBE3C Facilitates the ER-Associated and Peripheral Degradation of Misfolded CFTR

  2023cites this paper
• The NSAID glafenine rescues class 2 CFTR mutants via cyclooxygenase 2 inhibition of the arachidonic acid pathway

  2022cites this paper
• Modulator Combination Improves In Vitro the Microrheological Properties of the Airway Surface Liquid of Cystic Fibrosis Airway Epithelia

  2022cites this paper
• ER-phagy: mechanisms, regulation, and diseases connected to the lysosomal clearance of the endoplasmic reticulum

  2022cites this paper
• An unbiased screen identified the Hsp70-BAG3 complex as a regulator of myosin binding protein C3

  2022cites this paper
• Keratin 8 is a scaffolding and regulatory protein of ERAD complexes

  2022cites this paper
• Opposite regulation of F508del-CFTR biogenesis by four poly-lysine ubiquitin chains In vitro.

  2022cites this paper
• Mutation profiling of the c.1521_1523delCTT (p.Phe508del, F508del) cystic fibrosis transmembrane conductance regulator allele using haplotype‐resolved long‐read next generation sequencing

  2022cites this paper
• Rescue of Mutant CFTR Trafficking Defect by the Investigational Compound MCG1516A

  2022cites this paper
• Translational Research in Cystic Fibrosis: From Bench to Beside

  2022cites this paper
• Targeting trafficking as a therapeutic avenue for misfolded GPCRs leading to endocrine diseases

  2022cites this paper
• Pulmonary Safety Profile of Esc Peptides and Esc-Peptide-Loaded Poly(lactide-co-glycolide) Nanoparticles: A Promising Therapeutic Approach for Local Treatment of Lung Infectious Diseases

  2022cites this paper
• Identification of Novel F508del-CFTR traffic correctors among triazole derivatives.

  2022cites this paper
• Extracellular Vesicles’ Role in the Pathophysiology and as Biomarkers in Cystic Fibrosis and COPD

  2022cites this paper
• Using the genome to correct the ion transport defect in cystic fibrosis

  2022cites this paper
• ER-phagy responses in yeast, plants, and mammalian cells and their crosstalk with UPR and ERAD.

  2021cites this paper
• Lumacaftor and Matrine: Possible Therapeutic Combination to Counteract the Inflammatory Process in Cystic Fibrosis

  2021cites this paper
• Medically Important Alterations in Transport Function and Trafficking of ABCG2

  2021cites this paper
• Modulators of CFTR. Updates on clinical development and future directions.

  2021cites this paper
• Downregulation of epithelial sodium channel (ENaC) activity in human airway epithelia after low temperature incubation

  2021cites this paper
• Golgi Alpha1,2-Mannosidase IA Promotes Efficient Endoplasmic Reticulum-Associated Degradation of NKCC2

  2021cites this paper
• SLC26A9 is selected for endoplasmic reticulum associated degradation (ERAD) via Hsp70-dependent targeting of the soluble STAS domain.

  2021cites this paper
• Nonspecific binding of common anti-CFTR antibodies in ciliated cells of human airway epithelium

  2021cites this paper
• Cystic fibrosis

  2021cites this paper
• Revisiting CFTR Interactions: Old Partners and New Players

  2021influential citation
• The Targeting of Native Proteins to the Endoplasmic Reticulum-Associated Degradation (ERAD) Pathway: An Expanding Repertoire of Regulated Substrates

  2021cites this paper
• Differential Effects of STCH and Stress-Inducible Hsp70 on the Stability and Maturation of NKCC2

  2021cites this paper
• Esc peptides as novel potentiators of defective cystic fibrosis transmembrane conductance regulator: an unprecedented property of antimicrobial peptides

  2021cites this paper
• Distinct classes of misfolded proteins differentially affect the growth of yeast compromised for proteasome function

  2021cites this paper
• Pharmacological Modulation of Ion Channels for the Treatment of Cystic Fibrosis

  2021cites this paper
• Decreased proteasomal cleavage at nitrotyrosine sites in proteins and peptides

  2021cites this paper
• New Therapies to Correct the Cystic Fibrosis Basic Defect

  2021cites this paper
• FOXR1 regulates stress response pathways and is necessary for proper brain development

  2021cites this paper
• Improved correction of F508del-CFTR biogenesis with a folding facilitator and an inhibitor of protein ubiquitination.

  2021cites this paper
• Alterations of Nedd4‐2‐binding capacity in PY‐motif of NaV1.5 channel underlie long QT syndrome and Brugada syndrome

  2020cites this paper
• Molecular Physiology and Pharmacology of the Cystic Fibrosis Transmembrane Conductance Regulator

  2020cites this paper
• Molecular Mechanisms In Cftr-F508del Degradation And The Functional Defect Of Cftr Absence In Rabbits

  2020influential citation
• The Capture of a Disabled Proteasome Identifies Erg25 as a Substrate for Endoplasmic Reticulum Associated Degradation

  2020cites this paper
• Characterization of the Mechanism of Action of RDR01752, a Novel Corrector of F508del-CFTR.

  2020cites this paper
• The ABCG2/BCRP transporter and its variants – from structure to pathology

  2020cites this paper
• CFTR and Cystic Fibrosis: A Need for Personalized Medicine

  2020cites this paper
• Opposite Regulation of F508del-CFTR Biogenesis by Four Poly-Lysine Ubiquitin Chains

  2020cites this paper
• The ER-associated protease Ste24 prevents N-terminal signal peptide-independent translocation into the endoplasmic reticulum in Saccharomyces cerevisiae

  2020cites this paper
• Cystic Fibrosis: New Insights into Therapeutic Approaches

  2020cites this paper
• Ubiquitination of Disease-Causing CFTR Variants in a Microsome-Based Assay.

  2020cites this paper
• Combination of Selective PARP3 and PARP16 Inhibitory Analogues of Latonduine A Corrects F508del-CFTR Trafficking

  2020cites this paper
• Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease

  2020cites this paper
• Two-Step Mechanism of Cyclin B Degradation Initiated by Proteolytic Cleavage with the 26 S Proteasome in Fish

  2020cites this paper
• Forkhead box R1-mediated stress response linked to a case of human microcephaly and brain atrophy

  2020cites this paper
• CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine

  2020cites this paper
• Influenza A virus uncoating.

  2020cites this paper
• Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis

  2020cites this paper
• Cystic fibrosis from genotype to phenotype: review article

  2020cites this paper
• Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors

  2019cites this paper
• Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine

  2019cites this paper
• Chaperoning Endoplasmic Reticulum-Associated Degradation (ERAD) and Protein Conformational Diseases.

  2019cites this paper
• Folding–function relationship of the most common cystic fibrosis–causing CFTR conductance mutants

  2019cites this paper
• Protein Degradation and the Pathologic Basis of Disease.

  2019cites this paper
• CK19 stabilizes CFTR at the cell surface by limiting its endocytic pathway degradation

  2019influential citation
• Protein quality control in the secretory pathway

  2019cites this paper
• Different SUMO paralogues determine the fate of wild-type and mutant CFTRs: biogenesis versus degradation

  2019cites this paper
• Activity of lumacaftor is not conserved in zebrafish Cftr bearing the major cystic fibrosis‐causing mutation

  2019cites this paper
• Degradation of CFTR-F508del By the Ubiquitin E2 Conjugating Enzyme UBE 2L6 and the E3 Ligase RNF19B

  2019cites this paper
• Cystic Fibrosis: Proteostatic correctors of CFTR trafficking and alternative therapeutic targets.

  2019cites this paper
• Network Biology Identifies Novel Regulators of CFTR Trafficking and Membrane Stability

  2019cites this paper
• A posttranslational modification code for CFTR maturation is altered in cystic fibrosis

  2019cites this paper
• Pharmacological reversal of renal cysts from secretion to absorption suggests a potential therapeutic strategy for managing autosomal dominant polycystic kidney disease

  2019cites this paper